The HCPLive Vitiligo condition center page is a comprehensive resource for clinical news and insights on the dermatologic condition. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for the affected skin of vitiligo patients.
October 11th 2023
This new data from the phase 2b trial on povorcitinib could lead to developments in the dermatology space for vitiligo patients.